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In order to examine the role of the pituitary in the obese-hyperglycemic syndrome, obese (ob/ob) and
nonobese sibling (OB/?) mice were sham-operated or hypophysectomized by a parapharyngeal method at 60
to 90days ofage and subsequently weighed for nine weeks. Completeness ofhypophysectomy was assessed by
microscopic examination ofstained serial sections of the brain and attached hypophyseal capsule. Complete
hypophysectomy resulted in a moderate weight loss in the obese mice and attenuated further increases in
adiposity, but it failed to eliminate the adiposity already established prior to surgery as determined from Lee
index values. We tentatively conclude that neither the pituitary nor the target organs it controls represent the
site of the primary genetic abnormality that maintains the obesity of the ob/ob.
The obese-hyperglycemic syndrome (ob/ob) in mice, inherited as a single recessive
factor, arose in Jackson Laboratory stock in 1950. The syndrome is characterized by
excessive weight gain detectable by ten days of age [1] and by massive obesity
manifested both as hypertrophy and as hyperplasia ofadipocytes [2]. Inaddition, the
ob/ob shows increased food efficiency [1], hyperphagia [3], infertility [3], and
hyperinsulinemia identifiable by four weeks of age, followed by hyperglycemia [4].
Recent work has indicated that the obesity of the ob/ob is "metabolic": it persists
even when the food intake of the mouse is limited to control amounts [5]. Numerous
studies, in fact, suggest that the abnormal weight gain and metabolic aberrations of
the ob/ob may well be related to a defect in endocrine function.
First, both adrenal [6] and serum [7,8] corticosterone levels are elevated in the
ob/ob. Paradoxically, although both pituitary ACTH content and basal release of
ACTH in vitro are greatly elevated in obese mice, resting plasma ACTH levels are
normal [6]. Together these observations suggest the possibility of an abnormal
episodic release of ACTH combined with normal basal secretion in the ob/ob.
Adrenalectomy reduces but does not eliminate the weight gain in the ob/ob, and it
has a therapeutic effect on the abnormal levels of blood glucose and insulin [9,10].
Second, after finding evidence for increased incorporation of sulfate into costal
cartilage in obese mice compared to normals, Herbai, Westman, and Hellerstrom
[11] proposed a possible role for increased growth hormone secretion in the syn-
drome. This suggestion is apparently at odds with recent reports ofnormal or slightly
depressed basal plasma levels of immunoreactive growth hormone in obese mice
[12,13], as well as with the observation that abnormal weight gain attributed to the ob
gene occurs in dwarf ob/ob mice [14]. Nonetheless, given the pulsatile nature of
growth hormone secretion [15], the possibility remains that an exaggerated phasic
release of the hormone may contribute to the syndrome.
A substantial weight loss in the ob/ob mouse following hypophysectomy was
reported by Herbai [16]. However, the lack of adequate tests for completeness, the
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admitted possibility of brain damage owing to the transauricular surgical approach,
the failure to provide an optimal postoperative diet, and the rather briefobservation
period all make the results difficult to interpret. The object ofthe present study was to
examine the importance ofa hypothalamo-hypophyseal pathway in the expression of
the obese-hyperglycemic syndrome by reassessing the effect of hypophysectomy on
weight gain and adiposity. The results indicate that hypophysectomy does not
eliminate the obesity established prior to surgery, but that it does attenuate its further
development.
METHODS
Animals
Obese (ob/ob) mice and nonobese siblings (OB/?) were bred from matings of
C57B1/6J OB/ob males and females obtained from the Roscoe B. Jackson Memorial
Laboratory, Bar Harbor, Maine. Mice were weaned at 21 days of age, housed in
groups, and maintained ad libitum on D and G Type 81M pellets (8% fat) (Price-
Wilhoite Co.). The mouse colony was maintained at a temperature ofapproximately
26°C under conditions of 14 hrs of light and 10 hrs of dark. The mice were weighed
three times weekly, and as a measure of linear growth, nasal-anal lengths were
measured at surgery and again at sacrifice. Nasal-anal lengths were determined with
the anesthetized animals lying in the supine position.
Hypophysectomy
Obese (ob/ob) mice and nonobese siblings (OB/?) of both sexes were randomly
assigned to hypophysectomy (hypox) or sham-operated (sham) groups ateither 60 or
90 days of age (in the final analysis each experimental group was composed of three
animals that were 60 days of age at surgery and two that were 90 days of age). At
surgery, the mice received an i. p. injection of.08 cc atropine sulfate (.007 g/ml) after
which they were anesthetized with an i. p. injection of .025 g Tribromoethanol/cc
isotonic saline (dose .015 cc/gbw). Hypophysectomy was performed according to a
parapharyngeal method described by Plocher and Powley [17]. As a postoperative
prophylaxis against infection, all mice received daily i. p. injections of 10% Sulfad-
imethoxine (Bactrovet: Pitmann-Moore Co.) in an initial dose of .0043 cc/gbw and
subsequent doses of .0023 cc/gbw for one week after surgery. Dexamethasone
sodium phosphate (Decadron: Merck, Sharp, & Dohme) was diluted to a concentra-
tion of .20 mg/cc isotonic saline and administered s.c. to hypophysectomized mice.
Hypophysectomized nonobese siblings received an initial dose of .04 cc which
decreased daily to .01 cc on the seventh postoperative day, at which time replacement
therapy was terminated. In view of the reported adrenocortical hyperactivity in the
ob/ob, hypophysectomized obese mice received an initial dose of .10 cc of the
Decadron solution, which was decreased daily to a final dose of .01 cc ten days after
surgery, when the treatment was terminated. One-half of the sham-operated obese
mice and nonobese siblings were randomly designated to receive the same treatment.
The mice were housed one or two per cage and, in addition to the normal pelleted
diet, were given access to a wet mash composed of 84 g powdered Purina Rat Chow,
64 g Magnolia sweetened condensed milk, and 16 g sucrose in 150 ml water. The
hypophysectomy mortality rate was 62% for obese mice and 37% for nonobese
siblings.
Histology
Sixty days following surgery, the mice were sacrificed with an overdose of sodium
pentobarbitol and perfused intracardially with normal saline followed by 10% buf-
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fered formalin. Adrenals and gonads of hypophysectomized mice were observed for
signs of atrophy and, along with the livers and pancreases, were removed and stored
in formalin. The heads were stored in formalin for at least one week after which the
brains, with the investing membranes and hypophyseal capsule attached, were
dissected from the skull under a dissecting microscope and embedded in paraffin.
Serial coronal sections were cut at 5 microns and stained with cresyl violet. The
sections were observed under a light microscope with a projection attachment, and
the volume of any viable pituitary remnants was estimated from tracings drawn on
graph paper at a magnification of45X. The estimated volume ofpituitary tissue from
four sham-operated mice was used as a standard in the estimations.
Shih, Huang, and Peng [18] have demonstrated that hypophysectomized rats with
pituitary remnants of less than 1% normal volume are physiologically completely
hypophysectomized. This criterion of 1% was used in the present experiment. After
the initial screening in which nine of the surviving mice were discarded from the
experiment owing to a lack ofgonadal atrophy, microscopic analysis revealed that no
animal had pituitary remnants greater than 1% of normal volume. Thus, all 20
hypophysectomized mice retained for data analysis either had no pituitary remnants
or remnants estimated to be less than 1% normal volume. Further microscopic
examination of these 20 brains also indicated that there was no apparent damage to
the median eminence or ventral brain stem due to the hypophysectomy procedure.
Data Analysis
The Lee index [19], defined as 1000 X (body weight in g) 1/3/ nasal-anal length in
cm, has been shown to be a good estimate ofcarcass fat content in both rats [20]and
mice.' Thus, as a measure ofobesity the Lee index was computed for each ofthe 40
animals at surgery and again at sacrifice. All data were analyzed by analysis of
variance with multiple comparisons, according to the Neuman-Keuls procedure [21].
RESULTS
Fig. 1 depicts the body-weight changes ofmale ob/ob mice and nonobese (OB/?)
sibling males following hypophysectomy or sham-operation. Table 1 gives absolute
and percentage changes in body weight from surgery to sacrifice for both male and
female ob/ob and nonobese sibling mice. As illustrated in Fig. 1, male obese mice
weighed significantly more than nonobese sibling males at surgery (P's < .01 by
Neuman-Keuls tests). During the first week after surgery, males in all groups showed
a weight loss after which both of the sham-operated groups resumed weight gain.
Hypophysectomized sibling males lost weight for the first two weeks following
surgery, after which their weight stabilized and remained virtually constant until
sacrifice at Week 9. Male obese mice likewise responded to hypophysectomy with an
initial moderate weight loss followed by stabilization of body weight at a lowered
level. Multiple comparisons following a gene X hypox X sex analysis ofvariance on
the weight change data presented in Table 1 indicated that ob/ob and nonobese
sibling males did not differ significantly from each other in either their percentage
weight loss or absolute weight loss response to hypophysectomy. In contrast, while
both male sham groups gained weight over the nine weeks following surgery, sham-
operated ob/ob males significantly outgained sham siblings intotal (P< .01), but not
in percentage, weight gain.
Although hypophysectomy produced a moderate weight loss in ob/ob males, Fig.
1 clearly shows that hypox ob/ob males weighed significantly more than hypox
Significant positive correlations between percent fat content and Lee index (r445] = .86,p< .01) and between total
carcass fat content and Lee index (r445] = .87, p < .01) in mice have been reported by Plocher and Powley [17].
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FIG. 1. Weekly body-weight values (means ± SEM) for hypophysectomized (hypox) and sham-operated (sham) obese
(ob/ob) and nonobese sibling (OB/?) males. Only the positive or negative value of SEM is given. For each group of five
animals, surgery was performed at either 60 (N = 3) or 90 (N = 2) days of age.
TABLE 1
Mean (± SEM) Absolute and Percentage Change in Body Weight from Surgery to Sacrifice
% Absolute
Group N Change Change (g)
ob/ob e Hypox 5 -23.6 ± 4.0 -8.8 ± 1.5
ob/ob d Sham 5 24.6 ± 2.3 15.3 ± 1.0
OB/? e Hypox 5 -26.0 ± 5.9 -6.5 ± 1.6
OB/? e Sham 5 18.8 ± 3.1 6.6 ± 1.3
ob/ob ? Hypox 5 -17.6 ± 4.0 -6.8 ± 1.6
ob/ob ? Sham 5 21.6 ± 3.6 12.3 ± 2.0
OB/? F Hypox 5 -2.4 ± 4.5 -0.5 ± 1.1
OB/? 9 Sham 5 21.3 ± 1.7 6.5 ± 0.8
siblings throughout the experiment (all Ps < .01 by Neuman-Keuls comparisons).
Examination of the Lee indices presented in Table 2 further underscores the fact that
despite the moderate weight loss following hypophysectomy, ob/ob males remained
obese. The Lee index is also useful in assessing the observation that hypox ob/ob
males and sham-operated nonobese siblings did notdiffer significantly in bodyweight
at sacrifice. Although these two groups had similar body weights at sacrifice,
Neuman-Keuls comparisons showed that hypox ob/ob males were both significantly
shorter than sham sibling males (8.49 cm vs. 9.37 cm, P< .01) and more obese (389.6
vs. 342.7, P< .01).
Fig. 2 is a photograph of typical animals from each of the four male groups at
sacrifice. It is obvious from Fig. 2 that the hypox ob/ob is still massively obese
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TABLE 2
Mean (± SEM) Nasal-anal Length and Lee index
at Surgery and at Sacrifice
Nasal-anal length (cm) Lee indexa
Group N Surgery Sacrifice Surgery Sacrifice
ob/ob e Hypox 5 9.23 ± .08 8.49 ± .10 386.9 ± 3.9 389.6 ± 1.4
ob/ob e Sham] 5 9.16 ± .20 9.65 ± .17 392.1 ± 2.9 405.9 ± 6.3
OB/? d Hypox 5 9.16 ± .12 8.69 ± .19 342.0 ± 3.5 330.7 ± 6.7
OB/? d Sham 5 9.93 ± .07 9.37 ± .11 337.5 ± 3.7 342.7 ± 4.5
ob/ob ( Hypox 5 9.11 ± .12 8.40 ± .18 388.9 ± 5.3 396.7 ± 5.2
ob/ob S Sham 5 9.11 ± .09 9.43 ± .12 386.6-± 5.1 402.4 ±4.2
OB/? F Hypox 5 8.55 ± .08 8.19 ± .10 333.0 ± 3.3 344.7 ± 3.2
OB/? S Sham 5 8.57 ± .11 9.07 ± .11 333.1 ± 3.0 340.5 ± 4.8
aLee index = (,Ybody weight / nasal-anal length) X 1000
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FIG. 2. Photograph ofone animal fromeach ofthe fourmale groups 60days afterhypophysectomy orsham-operation.
Groupabbreviations are: OBESE = obese-hyperglycemic (ob/ob) mouse; SIBLING:: nonobese(OB/?) sibling; HYPOX =
hypophysectomized; SHAM = sham-operated.
compared to either the hypox or the sham-operated nonobese sibling. The figure also
shows the shorter nasal-anal lengths of the hypox animals compared to the sham
animals.
Fig. 3 shows the body weight changes offemale ob/ob and nonobese sibling mice
during the nine weeks following hypophysectomy or sham-operation. It can be seen
from Fig. 3 that ob/ob females responded to hypophysectomy in a manner similarto
ob/ob males. Hypox ob/ob and sibling females both showed a moderate weight loss
after surgery. After Week 1, hypox ob/ob females became nearly stabilized at the
lower body weight level with only a slight loss ofweight during the nexteight weeks.
Following an initial postoperative weight loss, hypox sibling females gradually
gained weight and, by Week 9, had nearly attained their preoperative weight.
Although weight gain was obviously retarded in the two hypox groups, multiple
comparisons following gene X hypox X sexanalysis ofvariance showed that both the
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FIG. 3. Weekly body-weight values (mean ± SEM) for hypophysectomized and sham-operated obese and nonobese
sibling females. Abbreviations and conventions are as in Fig. 1.
percentage and net weight losses of ob/ob females following hypophysectomy were
significantly greater than those of hypox sibling females (Ps < .01). In addition,
sham-operated ob/ob females showed a significantly greater total (P < .01), but not
percentage, weight gain during the nine weeks than sham sibling females.
Although ob/ob females lost more weight than sibling females following hypophy-
sectomy, they significantly outweighed both sham and hypox sibling females
throughout the experiment (Ps < .01) and, like hypox ob/ob males, maintained a
substantial obesity. Multiple comparisons following a gene x hypox X sex analysis of
variance on Lee index values at sacrifice clearly showed that hypox ob/ob females
were significantly more obese than their nonobese sham and hypox counterparts (Ps
< .01).
It is apparent from the above observations that hypox ob/ob mice are capable of
maintaining a substantial obesity. The very slight increases from surgery to sacrifice
in Lee index values of hypox obese mice compared to sham ob/ob controls, together
with the moderate weight loss following hypophysectomy in the obese mice, suggest
that hypophysectomy might have attenuated further development of the obesity.
Comparison of initial and final Lee indices by a gene X hypox X sex repeated-
measures analysis of variance indicated that, although final Lee indices of hypophy-
sectomized obese mice tended to be slightly greater than those at surgery, the increase
from surgery to sacrifice was nonsignificant. In contrast, a similar comparison
showed that final Lee indices of sham-operated ob/ob mice were significantly in-
creased over starting values (P < .01).
Finally, and as reported before [17], no effect of the Decadron treatment on the
body weights of the sham-operated mice was detected.
FEMALE
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DISCUSSION
The results of the present experiment demonstrate that, when inadvertant brain
damage due to surgical approach is avoided and when adequate postoperative care is
provided, complete hypophysectomy does not eliminate the obesity of the ob/ob
mouse. Our hypophysectomized obese mice maintained a massive state ofoverweight
compared to hypophysectomized siblings, and did not show a significant decrease in
adiposity as measured by the Lee index. On the other hand, hypophysectomy
apparently does attenuate the continued development ofobesity in the ob/ob mouse.
Despite their maintenance of a substantial obesity, hypophysectomized obese mice
showed a moderate postoperative weight loss. This weight loss appears not to be the
consequence of illness or general debility but rather to represent the same type (and
proportional degree) of reduction in body weight and composition typically reported
for nonobese animals following hypophysectomy. First, the bulk of the weight loss
occurred during the first few weeks following surgery, after which weight stabilized
and decreased only slightly over the remainder of the experiment. Furthermore,
another genetic obesity, that of the Yellow (Ay/a) mouse, on the same strain
background, develops quite unhindered by hypophysectomy under identical mainte-
nance conditions [17]. Alternatively, a comparison of the posthypophysectomy
weight loss of ob/ob mice with that of their nonobese sibling controls suggests that
ob/ob mice, in contrast to Yellow obese mice, display a fairly normal body weight
response to hypophysectomy. Normal rats respond to hypophysectomy by wasting
both fat and protein so that, despite a weight loss, the proportions of carcass
constituents remain fairly constant [22]. Similarly hypophysectomized nonobese
C57B1/6J mice also retain a nearly normal carcass composition in the presence ofa
moderate weight loss [17]. Thus, it is reasonable that-as the Lee indices suggest-
the moderate weight loss displayed by hypophysectomized ob/ob mice in the present
experiment was accompanied by little or no decrease in adiposity.
A significant decrease in nasal-anal length was also observed in hypophysectom-
ized obese and sibling mice. Hypophysectomy typically produces severe atrophy of
genital tissues and a loss of muscle tone possibly due to the abnormal utilization of
body protein mentioned above [22]. Both factors would tend to shrink perinealtissue
and produce a decrease in nasal-anal length. It should be added that all operated mice
in the present experiment which did not show a decrease in nasal-anal length at
sacrifice were subsequently found to have incomplete hypophysectomies. Similar
results for nasal-anal length have also been obtained in other hypophysectomy
experiments using the same measurement procedure [17,23].
Given the present data, several conclusions can be made about the role of
hypothalamo-hypophyseal pathways in the etiology of this obesity syndrome. Ifthe
obesity of the ob/ob were actively maintained by a primary hypersecretion of the
pituitary or its target organ hormones, hypophysectomy of two or three month old
obese mice should have not only attenuated further development of the obesity, but
also eliminated any obesity established prior to surgery. Although hypophysectomy
may retard the rate oflipolysis [24], hypophysectomized animals do lose fat [17,22],
and the long survival times used in the present experiment should have ensured that
any lipolysis-even retarded lipolysis-encouraged by removing the active source of
the obesity would have occurred. However, since the hypophysectomized mice in this
experiment remained obese despite an initial moderate weight loss, hypersecretion of
the pituitary or its target organs cannot be the sole primary defect underlying the
syndrome. It is, of course, plausible that the ob/ob's excess number of fat cells
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produced by hyperplasia [2] is responsible for sustaining much of the previously
established obesity in the absence of the pituitary.
While hypophysectomy did not eliminate the obesity already established by ob/ob
mice at the time of surgery, it did attenuate further development of obesity. This
result suggests that pituitary or pituitary-controlled secretions might have a permis-
sive role in supporting obesity development. Two possible mechanisms by which the
pituitary might act permissively to make possible the continued development of
obesity in the ob/ob mouse are particularly worthy ofconsideration. First, it is well
known that the pituitary is necessary for the normal long-term function of the
pancreatic islets [25,26,27]. A depression of both the rapid initial phase and the
slowly rising second phase ofinsulin secretion to a glucose stimulus has been reported
in isolated perfused pancreases of hypophysectomized rats [25]. Glucose-stimulated
insulin biosynthesis is also depressed following hypophysectomy [26]. Furthermore,
replacement therapy in hypophysectomized rats with either ACTH or hydrocortisone
restores both phases of the secretory response to glucose [25] while growth hormone
therapy restores the second phase of insulin secretion [25] and corrects the depressed
glucose-stimulated insulin biosyntheses [27]. As Genuth, Przybylski, and Rosenberg
[4] have suggested, the primary abnormality in the obese mouse might be an exagger-
ated insulin secretory response to the prevailing level ofglucose stimulation, perhaps
potentiated by an elevated release of a gastrointestinal insulinogogue, resulting in
hyperinsulinemia and obesity. If the work on islet function in hypophysectomized
rats generalizes to mice with the ob/ob genotype, then hypophysectomy, by depress-
ing the sensitivity of insulin biosynthetic and secretory mechanisms to glucose, might
render less effective the potentiating effects of any abnormal neural or hormonal
insulinogogue. With such an attenuation of the insulin response, weight gain might
well be attenuated also. While serum insulin levels were not measured in the present
study, adrenalectomy of obese mice reportedly produces a substantial reduction in
serum insulin levels, along with a reduction in weight gain [9].
A second mechanism by which the pituitary may act permissively in the ob/ob
syndrome is suggested by the observation that hypophysectomy in the rat nearly
abolishes the formation of primordial fat cells [28]. If the work on rats also general-
izes to mice, then hypophysectomy in the ob/ob should prevent further hyperplasia
of fat cells. Furthermore, Herberg and his co-workers [29] have shown that fat cell
size in the ob/ob reaches a maximum at two-three months ofage. As suggested by
these authors, the continued abnormal fattening and weight gain of the ob/ob after
this time can only be understood in terms of a continued hyperplasia of fat cells. If
continued increases in adiposity after two to three months of age rely mainly on fat
cell hyperplasia, and if hypophysectomy indeed blocks adipocyte hyperplasia in the
ob/ob, then the attenuation of further increases in adiposity along with the mainte-
nance of previously established obesity seen in the present experiment can be
understood. Hypophysectomy of the genetically obese Zucker rat (fa/fa) also results
in an attenuation of further increases in adiposity without eliminating the obesity
present at surgery [23]. It is noteworthy that the ob/ob mouse and Zucker rat are the
only rodent obesities that rely predominantly on adipocyte hyperplasia as a means
for excessive fat accumulation [2,30]. It is tempting to speculate that the pituitary
plays a similar, permissive role in the abnormal fat cell hyperplasia ofboth the ob/ob
mouse and Zucker rat. Furthermore, the similarities between the two models of
obesity suggest that a classification ofobesities according to adipocyte cellularity may
well be heuristically valuable in understanding the various etiologies of obesity.
Studies ofadipocyte cellularity in hypophysectomized ob/ob mice and Zucker rats at
several stages of development are obviously needed to evaluate these hypotheses.
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